Janssen’s MS treatment Ponvory is granted UK marketing authorisation
August 11, 2021Research and Development
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Marketing Authorisation in Great Britain for PONVORY (ponesimod) for the …
Sputnik V vaccine 13% less effective against Delta than originally reported
August 11, 2021Medical Communications, Research and Development
Russian health officials have announced that the Sputnik V COVID vaccine is 83% effective against the Delta variant on Wednesday, …
More than 75% of UK adults have been double jabbed
August 11, 2021Research and Development
More than 75% of adults living in the UK have now received both doses of the vaccine, as announced by …
Moderna and Canada to collaborate on mRNA manufacturing
August 11, 2021Manufacturing and Production, Research and Development
Moderna will build a messenger RNA (mRNA) vaccine manufacturing facility in Canada, which will include access to Moderna’s mRNA development …
Kite receives positive recommendation from SMC for CAR T therapy
August 10, 2021Manufacturing and Production, Research and Development
Kite has announced a positive recommendation from the Scottish Medicines Consortium (SMC) on the company’s Healthcare Technology Assessment for Tecartus, …
Researchers develop injectable hydrogel to combat Parkinson’s
August 10, 2021Medical Communications, Research and Development
An Australian research team has developed a hydrogel that can be used as a one-off intervention to treat Parkinson’s disease, …
AI system may be able to detect dementia in a day
August 10, 2021Manufacturing and Production, Medical Communications, Research and Development
Researchers from Cambridge University and The Alan Turing Institute have developed an artificial intelligence (AI) system that can diagnose dementia …
Moderna could offer better defence against Delta variant than Pfizer
August 10, 2021Manufacturing and Production
Pfizer-BioNTech’s mRNA could be less effective than Moderna’s against the Delta variant of COVID-19. In a study of more than …
Scotland approves Merck and Pfizer’s Bavencio for bladder cancer
August 10, 2021Manufacturing and Production
Merck and Pfizer’s Bavencio (avelumab) has been approved by approved by the Scottish Medicines Consortium (SMC) for use via NHS …
Researchers develop new method to kill bacteria on medical implants
August 9, 2021Medical Communications, Research and Development, Sales and Marketing
Researchers from Chalmers University of Technology, Sweden, have developed a new method to prevent bacterial infections relating to medical implants …
‘Potential’ link between vaccines and menstruation changes
August 9, 2021Sales and Marketing
France’s health body has said changes in women’s menstrual cycles are a “potential” side effect of receiving the Moderna or …
Psoriasis treatment bimekizumab maintains high Levels of skin clearance
August 9, 2021Sales and Marketing
New two-year data has shown that bimekizumab maintained high Levels of skin clearance in patients with moderate to severe plaque …
First new adult CDK treatment in 20 years gains UK and EU approval
August 9, 2021Medical Communications, Research and Development, Sales and Marketing
AstraZeneca has announced the EU approval of Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, alongside a licence extension from …
FDA approves Nexviazyme as treatment for late-onset Pompe disease
August 9, 2021Sales and Marketing
The FDA has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset …
Sierra Oncology to licence myelofibrosis candidate from AstraZeneca
August 6, 2021Medical Communications, Research and Development, Sales and Marketing
Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …
Gilead warns of counterfeit HIV medication being distributed in US
August 6, 2021Medical Communications
Gilead have released a statement warning of tampered and counterfeit versions of its once-daily single tablet HIV treatment regimen Biktarvy …
Libtayo Phase III Trial stopped early due to significant improvement in overall survival
August 6, 2021Medical Communications
The Phase III trial of Sanofi and Regeneron’s PD-1 inhibitor Libtayo in combination with platinum-doublet chemotherapy was stopped early due …
FDA grants Orphan Drug Designation to sotigalimab for soft tissue sarcoma
August 6, 2021Medical Communications
The FDA has granted Apexigen’s sotigalimab (APX005M) Orphan Drug Designation for the treatment of soft tissue sarcoma.Sotigalimab, Apexigen’s lead therapeutic …
Cholesterol pill could cut COVID infections by up to 70%, study finds
August 6, 2021Medical Communications, Research and Development
A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce COVID infections by …
Fresenius launches VR training for home dialysis in Germany
August 5, 2021Fresenius has launched a virtual reality-based training programme, stay safe My Training VR, for people undergoing at home dialysis.The VR …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
